A histological study of the effect of exogenous melatonin on gentamicin induced structural alterations of proximal tubules in rats

Bosnian Journal of Basic Medical Sciences

Volumn 14, Issue 1, 2014, Pages 30-34

  Kapić, Dina ^a   Mornjaković, Zakira ^a   Ćosović, Esad ^a   Šahinović, Maida ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Gentamicin; Histological analysis; Melatonin; Proximal tubules; Rats

Indexed keywords

ANTIOXIDANT; GENTAMICIN; MELATONIN; PROTEIN SYNTHESIS INHIBITOR;

ANIMAL; ARTICLE; CHEMISTRY; CYTOPLASM; DOSE RESPONSE; DRUG EFFECT; INTRAPERITONEAL DRUG ADMINISTRATION; KIDNEY; KIDNEY PROXIMAL TUBULE; MALE; METABOLISM; NECROSIS; OXIDATIVE STRESS; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; CYTOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENTAMICINS; INJECTIONS, INTRAPERITONEAL; KIDNEY; KIDNEY TUBULES, PROXIMAL; MALE; MELATONIN; NECROSIS; OXIDATIVE STRESS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR;

EID: 84897903281     PISSN: 15128601     EISSN: 18404812     Source Type: Journal    
DOI: 10.17305/bjbms.2014.2293     Document Type: Article

References (23)

1. Ali BH, Al Za'abi M, Blunden G, Nemmar A. Experimental genta-micin nephrotoxicity and agents that modify it: a mini-review of recent research. Basic Clin Pharmacol Toxicol 2011; 109(4): 225-232.
2. Kahlmeter G, Dahlager JI. Aminoglycoside toxicity-a review of clinical studies published between 1975 and 1982. J Antimicrob Chemother. 1980; 13 Suppl A: 9-22.
3. Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother. 1999; 43(5): 1003-1012.
4. Lopez-Novoa JM, Quiros Y, Vicente L, Morales AI, Lopez-Hernan-dez FJ. New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int 2011; 79(1): 33-45.
5. Martínez-Salgado C, Eleno N, Tavares P, Rodríguez-Barbero A, García-Criado J, Bolaños JP, et al. Involvement of reactive oxygen species on gentamicin-induced mesangial cell activation. Kidney Int 2002; 62(5):1682-1692.
6. Kacew S, Bergeron MG. Pathogenic factors in aminoglycoside induced nephrotoxicity. Toxicol Lett 1990; 51(3): 241-59.
7. Leehey DJ, Braun BI, Tholl DA, Chung LS, Gross CA, Roback JA, et al. Can pharmacokinetic dosing decrease nephrotoxicity associated with aminoglycoside therapy. J Am Soc Nephrol 1993; 4(1): 81-90.
8. Cuzzocrea S, Mazzon E, Dugo L, Serraino I, Di Paola R, Britti D, De Sarro A, Pierpaoli S, Caputi A, Masini E, Salvemini D. A role for superoxide in gentamicin-mediated nephropathy in rats. Eur J Pharmacol. 2002; 450(1): 67-76.
9. Banday AA, Farooq N, Priyamvada S, Yusufi AN, Khan F. Time dependent effects of gentamicin on the enzymes of carbohydrate metabolism, brush border membrane and oxidative stress in rat kidney tissues. Life Sci 2008; 82(9-10): 450-459.
10. Kurcer Z, Oguz E, Ozbilge H, Baba F, Aksoy N, Celik H, et al. Melatonin protects from ischemia/reperfusion-induced renal injury in rats: this effect is not mediated by proinflammatory cytokines. J Pineal Res 2007; 43(2):172-178.
11. Parlakpinar H, Sahna E, Ozer MK, Ozugurlu F, Vardi N, Acet A. Physiological and pharmacological concentrations of melatonin protect against cisplatin-induced acute renal injury. J Pineal Res 2002; 33(3): 161-166.
12. Nowak R, McMillen IC, Redman J, Short RV. The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: two non-invasive techniques for monitoring human circadian rhythmicity. Clin Endocrinol (Oxf) 1987; 27(4): 445-452.
13. Sutherland ER, Martin RJ, Ellison MC, Kraft M. Immunomodulatory effects of mela-tonin in asthma. Am J Respir Crit Care Med 2002; 166(8): 1055-1061.
14. Mayo JC, Sainz RM, Tan DX, Hardeland R, Leon J, Rodriguez C, et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005; 165(1-2): 139-149.
15. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005; 27: 119-130.
16. Reiter RJ, Tan DX, Sainz RM, Mayo JC, Lopez-Burillo S. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002; 54(10): 1299-1321.
17. Houghton DC, Plamp CE 3rd, DeFehr JM, Bennett WM, Porter G, Gilbert D. Gentamicin and tobramycin nephrotoxicity: a morphologic and functional comparison in the rat. Am J Pathol 1978; 93: 137-151.
18. Martínez-Salgado C, López-Hernández FJ, López-Novoa JM. Glomerular nephrotoxicity of aminoglycosides. Toxicol Appl Pharmacol 2007; 223(1): 86-98.
19. Yazar E, Elmas M, Altunok V, Sivrikaya A, Oztekin E, Birdane YO. Effects of aminoglycoside antibiotics on renal antioxidants, malo-ndialdehyde levels, and some serum biochemical parameters. Can J Vet Res 2003; 67(3): 239-240.
20. Sener G, Sehirli AO, Altunbas HZ, Ersoy Y, Paskaloglu K, Arbak S, et al. Melatonin protects against gentamicin-induced nephrotoxicity in rats. J Pineal Res 2002; 32(4): 231-236.
21. Shifow AA, Kumar KV, Naidu MU, Ratnakar KS. Melatonin, a pineal hormone with antioxidant property, protects against gentami-cin-induced nephrotoxicity in rats. Nephron 2000; 85(2):167-174.
22. Ozbek E, Turkoz Y, Sahna E, Ozugurlu F, Mizrak B, Ozbek M. Melatonin administration prevents the nephrotoxicity induced by gentamicin. BJU Int 2000; 85(6): 742-746.
23. Lee IC, Kim SH, Lee SM, Baek HS, Moon C, Kim SH, et al. Melatonin attenuates gentamicin-induced nephrotoxicity and oxidative stress in rats. Arch Toxicol 2012; 86(10):1527-1536.